🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As we approach the first ever AMKD Awareness Day on April 30, AKF, together with advocates across the country, is working to secure #proclamations from #stategovernors for this new observance from coast to coast. Find your state contact and submit today: bit.ly/3woCZ2A

The most powerful way to raise awareness is by sharing personal stories, and AKF wants to hear yours. Tell us how APOL1-mediated kidney disease has impacted the lives of you or your loved ones by submitting a short video to help make others #APOL1Aware: bit.ly/3P3P9oa

As we approach the first ever AMKD Awareness Day on April 30, AKF, together with advocates across the country, is working to secure #proclamations from #stategovernors for this new observance from coast to coast. Find your state contact and submit today: bit.ly/3woCZ2A

I’m joining American Kidney Fund for AMKD Awareness Day on 4/30. Those of certain African descent may be at increased risk of having APOL1 gene variants that may lead to AMKD. I encourage you to become #APOL1Aware! Visit kidneyfund.org/APOL1aware to learn more #AKFAmbassador

We all have 2 copies of the APOL1gene, but some people have a mutation in one or both genes, increasing their risk of developing kidney disease. Learn more about APOL1-mediated kidney disease (AMKD) & become #APOL1Aware: bit.ly/42GM5T6

The most powerful way to raise awareness is by sharing personal stories, and AKF wants to hear yours. Tell us how APOL1-mediated kidney disease has impacted the lives of you or your loved ones by submitting a short video to help make others #APOL1Aware: bit.ly/3P3P9oa

Everyone has two APOL1 genes. But for people with a certain variation of the APOL1 genes, there is an increased risk of developing APOL1-mediated kidney disease (AMKD). Help raise awareness by joining our efforts for AMKD Awareness Day on April 30: bit.ly/3IgH4sl

Today, AKF and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness. Read more: bit.ly/4cLTzdr

Did you know that 1 in 5 Black Americans with 2 variations of the APOL1 gene have a chance of developing kidney disease? Learn more about APOL1-mediated kidney disease (AMKD) & help others become #APOL1Aware with AKF’s AMKD Awareness Day toolkit: bit.ly/3ITpD1o

In anticipation of the first AMKD Awareness Day on April 30, AKF went to Capitol Hill to host a roundtable and policy discussion about APOL1-mediated kidney disease (AMKD) led by AKF CEO and President LaVarne Burton.

AMKD Awareness Day is sponsored by Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals

After finding out that she has an APOL1 gene variant, Emani was able to get the answers she needed to take the next steps in her kidney disease journey. Learn more about APOL1-mediated kidney disease & join AMKD Awareness Day on April 30: bit.ly/3IgH4sl #APOL1Aware

Everyone has two APOL1 genes. But for people with a certain variation of the APOL1 genes, there is an increased risk of developing APOL1-mediated kidney disease (AMKD). Help raise awareness by joining our efforts for AMKD Awareness Day on April 30: bit.ly/3IgH4sl

Become #APOL1Aware and join American Kidney Fund for AMKD Awareness Day on April 30. Learn more about APOL1’s connection to kidney disease and spread the word: kidneyfund.org/APOL1aware #GeneChat

Ahead of AMKD Awareness Day, join AKF President & CEO LaVarne Burton and Mike Spigler, AKF Vice President of Patient Support & Education, as they sit down with AKF Ambassador Quenton Turner-Gee to discuss living with AMKD. Attend tomorrow’s NMQF webinar: bit.ly/3UCc9xS

Join AKF President & CEO LaVarne Burton and AKF VP of Patient Support & Education for a Q&A with AKF Ambassador Quenton Turner-Gee about his experience living with AMKD. Attend today's NMQF webinar at 12PM ET: bit.ly/3UCc9xS

Proud to have Dr Gentzon Hall lead the new GlomCon Mentored Internship Program in Nephrology (MIPiN) with Dr Nina Smith Associate Dean North Carolina Central University

More information here glomcon.org/mentored-inter…

Pathogenic mutations in _CRB2_ gene have been shown to cause early-onset corticosteroid-resistant nephrotic syndrome (SRNS)/FSGS. This month, in AJP Renal publish podocytic studies on a 2-generation Indian kindred with biopsy-proven FSGS caused by a compound heterozygous mutation

Hey Margot Savoy MD, MPH, FAAFP, I hope all is well with you. I’ve been trying to track you down to catch up and to run some things by you. Let me know when you have some time to chat with a. Old friend from UMB. Look forward to connecting - Gentzon.